Insider · CIK 0001668858

Mann Brenda

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001668858

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-11-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−62 sh	$1.98	−$122.76	15,136
2021-10-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−62 sh	$2.01	−$124.62	15,198
2021-09-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−61 sh	$1.81	−$110.41	15,260
2021-08-03	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−63 sh	$2.40	−$151.2	15,321
2021-07-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−154 sh	$3.70	−$569.8	15,384
2021-06-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−155 sh	$4.19	−$649.45	15,538
2021-05-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−191 sh	$4.13	−$788.83	15,693
2021-04-08	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−192 sh	$4.94	−$948.48	15,884
2021-03-03	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−192 sh	$5.46	−$1,048.32	16,076
2021-02-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−988 sh	$6.34	−$6,263.92	16,268
2021-02-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Research & Development	AAward	+10K sh	—	—	10,000
2021-01-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−115 sh	$4.85	−$557.75	17,256
2020-12-07	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−91 sh	$3.76	−$342.16	17,371
2020-11-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−96 sh	$3.51	−$336.96	17,462
2020-10-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−98 sh	$3.88	−$380.24	17,558
2020-09-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−97 sh	$3.94	−$382.18	17,656
2020-08-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−92 sh	$4.11	−$378.12	17,753
2020-07-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−94 sh	$4.82	−$453.08	17,845
2020-06-03	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−94 sh	$5.11	−$480.34	17,939
2020-05-05	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−113 sh	$5.10	−$576.3	18,033
2020-04-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−122 sh	$4.97	−$606.34	18,146
2020-03-09	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−130 sh	$5.00	−$650	18,268
2020-02-14	KPRXKIORA PHARMACEUTICALS INCA Award	VP of Research & Development	AAward	+7,500 sh	—	—	18,398
2020-02-14	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Research & Development	AAward	+7,500 sh	—	—	7,500
2020-02-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−109 sh	$6.00	−$654	10,898
2020-01-03	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−119 sh	$9.52	−$1,132.88	11,007
2019-12-18	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−101 sh	$7.46	−$753.46	11,126
2019-11-05	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−107 sh	$3.85	−$411.95	11,227
2019-10-09	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−184 sh	$3.12	−$574.08	11,334
2019-08-06	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Research & Development	FTax Payment	−1,641 sh	$0.21	−$344.61	172,783
2019-07-15	KPRXKIORA PHARMACEUTICALS INCS Sale	VP of Research & Development	SSale	−6,350 sh	$0.23	−$1,479.55	174,424
2019-07-12	KPRXKIORA PHARMACEUTICALS INCS Sale	VP of Research & Development	SSale	−6,350 sh	$0.24	−$1,496.06	180,774
2019-07-11	KPRXKIORA PHARMACEUTICALS INCS Sale	VP of Research & Development	SSale	−6,349 sh	$0.24	−$1,527.569	187,124
2019-02-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Research & Development	AAward	+50K sh	—	—	50,000
2018-07-10	KPRXKIORA PHARMACEUTICALS INCA Award	VP of Research & Development	AAward	+175K sh	—	—	193,473
2018-02-28	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Research & Development	AAward	+15K sh	—	—	15,000
2017-12-29	KPRXKIORA PHARMACEUTICALS INCJ Other	VP of Research & Development	JOther	+6,722 sh	$1.01	+$6,789.22	18,473
2017-06-21	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Research & Development	AAward	+15K sh	—	—	15,000
2017-02-06	KPRXKIORA PHARMACEUTICALS INCA Award	VP of Research & Development	AAward	+2,500 sh	—	—	11,751
2016-07-18	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Research & Development	AAward	+1,133 sh	—	—	1,133
2016-03-29	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Research & Development	AAward	+851 sh	—	—	851
2016-03-07	KPRXKIORA PHARMACEUTICALS INCJ Other	VP of Research & Development	JOther	+9,251 sh	—	—	9,251
2016-03-07	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Research & Development	AAward	+9,500 sh	—	—	9,500

Recent filings

Accepted (ET)
Nov 34
Mann Brenda0001104659-21-133652
SEC(opens sec.gov)
Oct 54
Mann Brenda0001104659-21-123266
SEC(opens sec.gov)
Sep 34
Mann Brenda0001104659-21-112937
SEC(opens sec.gov)
Aug 44
Mann Brenda0001104659-21-100197
SEC(opens sec.gov)
Jul 64
Mann Brenda0001104659-21-089443
SEC(opens sec.gov)
Jun 74
Mann Brenda0001104659-21-077763
SEC(opens sec.gov)
May 54
Mann Brenda0001104659-21-061946
SEC(opens sec.gov)
Apr 94
Mann Brenda0001104659-21-048712
SEC(opens sec.gov)
Mar 54
Mann Brenda0001104659-21-032763
SEC(opens sec.gov)
Feb 34
Mann Brenda0001104659-21-011852
SEC(opens sec.gov)
Jan 54
Mann Brenda0001104659-21-000927
SEC(opens sec.gov)
Dec 84
Mann Brenda0001104659-20-133326
SEC(opens sec.gov)
Nov 34
Mann Brenda0001104659-20-120954
SEC(opens sec.gov)
Oct 54
Mann Brenda0001104659-20-112300
SEC(opens sec.gov)
Sep 34
Mann Brenda0001104659-20-102299
SEC(opens sec.gov)
Aug 54
Mann Brenda0001104659-20-090917
SEC(opens sec.gov)
Jul 64
Mann Brenda0001104659-20-081219
SEC(opens sec.gov)
Jun 44
Mann Brenda0001104659-20-069823
SEC(opens sec.gov)
May 64
Mann Brenda0001104659-20-057472
SEC(opens sec.gov)

Companies

KIORA PHARMACEUTICALS INCVP of Research & DevelopmentKPRX

Address

C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLEY OAKS ROAD, SUITE 108

WALTHAM, MA, 02452